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Mechanisms of Escape from Host Immune Defenses by Apicomplexan Parasites 
Review Article by Reannan Barlow 
Overview: 
A successful pathogen manipulates its host from the moment infection occurs. Apicomplexan parasites are no 
different. Plasmodium spp., the causative agents of malaria, evade the human immune system so well that they 
kill hundreds of thousands of people per year. Toxoplasma, though not particularly dangerous to a healthy adult, 
is a widespread pathogen due to how easily it spreads between host and how it modulates host functions (27). 
This review discusses how Toxoplasma and Plasmodium avoid clearance by host defenses, highlighting their 
similarities and differences. 
Background: 
Malaria: 
Malaria is an arthropod-borne disease resulting from an infection with a protozoan parasite of the genus 
Plasmodium belonging to the phylum Apicomplexa (14). This parasite is arguably, one of the deadliest parasites 
across the globe. According to the World Health Organization, there were roughly 228 million cases of malaria 
worldwide and 405,000 deaths in 2018 (10). Most of these cases were in sub-Saharan Africa, infecting mainly 
children (14). Two hosts are vital for the lifecycle of Plasmodium, the mosquito vector, and a vertebrate host 
(9). In this review, the vertebrate host of focus will be humans. 
In humans, the parasite will undergo two distinct stages. The first is called the liver stage; during this period, 
individuals are asymptomatic. The second stage is the blood stage, during which people experience symptoms 
(fever, chills, nausea, etc.) (17). The lifecycle of malaria begins when a malaria-infected female mosquito takes 
a blood meal from a human. During the blood meal, thousands of sporozoites are deposited into the skin of the 
individual. The sporozoites travel to the liver, where they mature into schizonts. The schizonts eventually 
rupture, releasing merozoites into the bloodstream. The merozoites infect red blood cells. In the red blood cell, 
the parasite will differentiate into gametocytes or mature trophozoites. The mature trophozoites develop into 
schizonts, which will all be released when the red blood cell ruptures. The gametocytes can then be taken up by 
another mosquito during a blood meal, and the schizonts will infect more red blood cells, continuing the cycle 
(7).  
Toxoplasmosis: 
Toxoplasmosis is a disease due to infection with another protozoan parasite in the phylum Apicomplexa called 
Toxoplasma gondii. Infections with T. gondii in a healthy adult are usually mild; however, there are serious 
complications that result from infection in utero or an immunocompromised individual (5). Due to this 
parasite's relevance in veterinary and medical fields, it is one of the most well-studied parasites. A standard 
route of human infection with T. gondii is via domestic cats, the definitive host (33). In intermediate hosts, like 
humans, T. gondii undergoes two phases. In the first phase, Tachyzoites multiply quickly by repeated 
endodyogeny in various host cells. In the second phase of development, some tachyzoites convert to bradyzoites 
that form tissue cysts. In the cysts, bradyzoites replicate slowly by endodyogeny. These cysts have a high 
affinity for the central nervous system, eyes, skeletal muscle, and cardiac muscle (31). The tissue cysts formed 
are infectious. An individual can get toxoplasmosis via horizontal transmission due to the ingestion of oocytes 
from the environment or eating undercooked meat containing tissue cysts, or by vertical transfer across the 
placenta. Definitive hosts can infect intermediate hosts and vice versa (31). 
The success of Toxoplasma gondii stems from how easily transmission between the definitive and intermediate 
hosts occurs. This parasite can modulate the host cell to develop a chronic infection while evading the immune 
system and anti-toxoplasmosis drugs. There is a delicate balance between stimulating and avoiding the host's 





MALARIA PRE-ERYTHROCYTIC STAGE IMMUNE EVASION 
 
1. Outsmarting the Mechanical Barrier 
The skin has a multitude of immune functions. It acts as a barrier, and when a pathogen crosses the epithelium, 
the complement system is activated (3). For the Plasmodium parasite to successfully establish infection, it must 
evade this first defense system. The mosquito vector assists with this process; when the mosquito bites, it injects 
vasodilators, anticoagulants, and immunomodulators from its salivary glands. This promotes the survival and 
injection of the sporozoites (35).  
Another innate immune defense present in the skin are phagocytes; these are cells that can phagocytose or 
ingest invading pathogens. The freshly injected sporozoites must avoid these cells to make it to the liver. They 
do this by their ability to migrate. One-way sporozoites migrate through the host dermis is via cell traversal. A 
protein called sporozoite microneme protein essential for cell traversal (SPECT) allows for the penetration of 
host cells for cell traversal. It was found that sporozoites deficient in SPECT were impaired in the skin and 
eradicated by phagocytes. Therefore, SPECT is one protein necessary for the parasite to evade the skin's 
immune functions and successfully travel to the liver to continue its lifecycle (14). 
 
2. Silencing Kupffer Cells 
Plasmodium uses cell traversal to travel through Kupffer cells (KCs) as well. Kupffer cells are macrophages in 
the liver that help prevent pathogens from invading hepatocytes. KCs prevent infection through various 
mechanisms, a few that malaria takes advantage of are the release of pro-inflammatory cytokines and reactive 
oxygen species. It was found that the circumsporozoite protein (CSP) binds to low-density lipoprotein receptor-
related protein (LRP-1) and proteoglycans on the KCs, which prevents the formation of reactive oxygen species 
due to an increase in cAMP/EPAC (34,35). This mechanism disarms the KCs, allowing for the spread of the 
Plasmodium parasite. 
Another way the KCs protects hepatocytes is by releasing inflammatory cytokines when a pathogen invades. 
However, when sporozoites encounter KCs, they downregulate the release of inflammatory cytokines like TNF-
α, IL-6, and MCP-1 while upregulating the release of IL-10, an anti-inflammatory cytokine (19,35). The 
infection of sporozoites decreases the expression of MHC I on Kupffer cells and causes KCs death via apoptosis 




Figure 1: Sporozoites inhibit the function of KCs. Binding of the sporozoite CSP to proteoglycans and LRP-1 on the KC causes an increase in 
cAMP/EPAC levels, ultimately preventing the formation of reactive oxygen species (left). Sporozoites also cause a decrease in the release of 
inflammatory cytokines and an increase in anti-inflammatory cytokines and induce KC apoptosis (right)  (19). 
 
3. Controlling Hepatocytes 
Once in the liver, the Plasmodium parasite must invade hepatocytes and mature into exoerythrocytic forms 
(EEFs). Sporozoites travel through many hepatocytes before they reach the final liver cell, in which they will 
differentiate into merozoites (23,35). This parasite has refined a few ways to repress the function of hepatocytes 
while preventing cell death. One-way Plasmodium does this is by transporting CSP into the cytoplasm of the 
hepatocyte. Once CSP is in the cytoplasm, it binds ribosomes overall, inhibiting host cell protein synthesis 
(11,29,35). Also, the release of CSP into the cytoplasm results in a suppression of nuclear factor-κB (NFκB), 
which is an important transcription factor centrally involved in stimulating inflammation (29,35).  
Once the sporozoite differentiates into a merozoite within the hepatocyte, it must successfully leave the cell to 
proceed with its lifecycle in the blood. Again, the Plasmodium parasite must evade the host's immune system to 
do so. During the process of exiting the hepatocyte, the merozoite will be vulnerable to host immune cells like 
KCs and dendritic cells (DCs). To bypass the KCs and DCs, merozoites will exit the hepatocytes via 
merosomes, which are packets of merozoites coated in host cell membranes (30). Traveling in a vessel made of 
host cell material allows the parasite to exit the hepatocyte undetected (8,19). During the budding process, the 
hepatocyte infected with malaria dies. However, the merozoites uptake calcium and sustain low levels of 
calcium to prevent phosphatidylserine (PS) exposure on the outer membrane. Without the PS tag, the infected, 
dying hepatocyte is not recognized by phagocytes. Therefore, the merozoite can continue to the next stage of its 
lifecycle (8,30).   
 
MALARIA ERYTHROCYTIC STAGE IMMUNE EVASION 
 
1. Lacking MHC I 
MHC 1 is major histocompatibility complex 1, which is expressed in all cells that contain a nucleus. It functions 
to present segments of pathogens to cytotoxic T cells to trigger an immune response. Once merozoites exit 
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hepatocytes, they infect red blood cells (RBCs) and mature into trophozoites. The RBC will eventually burst, 
releasing many trophozoites that can continue contaminating more RBCs (12). Infecting RBCs leans in favor of 
the parasite due to RBCs lacking a nucleus and, therefore, not having MHC I. In addition to lacking MHC I, the 
terminally differentiated RBC, is also unable to initiate a cell-autonomous immune response upon infection. The 
malaria parasite thereby goes undetected and escaping clearance by immune cells, like cytotoxic T cells, etc. (6)  
 
2. Forming Rosettes and Sequestrating  
The Plasmodium parasite induces the formation of rosettes in order to avoid immune defenses of the host. 
Another benefit to forming rosettes is infected RBCs are clustered with uninfected RBCs, allowing for more 
efficient spreading of the parasite. The Plasmodium parasite can quickly invade new RBCs when they are 
aggregated around a bursting RBC, assisting in avoidance of immune recognition (22).  
Blood type can also affect how well RBCs form rosettes. An individual with blood type A forms stronger 
rosettes than an individual with blood type O. Therefore, there is a slight advantage for the parasite when it is 
inoculated into a person with blood type A (22). 
Proteins from genes like Var and Rifin allow infected RBCs to attach to vascular endothelium sequestering in 
the microvasculature of organs, helping the parasite to avoid clearance (18,24). The spleen is important for 
filtering the blood for pathogens and ridding the blood of old erythrocytes (21). Proteins encoded by Var genes 
are known as PfEMP1 and localized to the RBC surface. They are expressed one at a time and the parasite 
periodically switches from the expression of one Var gene to another, allowing the parasite to evade the 
immune response the host mounts against each successive PfEMP1 variant (26). Along with this, these proteins 
also affect host platelets and inflammation, which leads to agglutination of uninfected RBCs with the infected 
ones, again assisting with the spread of infection (18). Sequestration in these microenvironments prevents 
infected RBC clearance by the spleen and helps the spread of the parasite. 
 
3. Avoiding Recognition by Antibodies 
Antibodies are essential to host protection during the blood stage of malaria. Antibodies can recognize antigens 
on the parasite or the parasite-infected RBC (32). Antibodies can block processes like adhesion and invasion of 
the parasite. Therefore, Plasmodium as successful as it is must-have ways to avoid these defenses. IgG subclass 
of antibodies, specifically IgG3, have shown protection against malaria parasites in the blood stage and target 
antigens like merozoite surface protein 1 (32). However, merozoite surface proteins (MSPs) are used by the 
parasite to avoid immune attack and show strong homology to host proteins, making it difficult for antibodies to 
recognize MSPs (5). 
 
 
TOXOPLASMOSIS IMMUNE EVASION: 
 
1. Revamping Host Transcription Factors 
Toxoplasma modulates more than 1000 host genes that regulate inflammation, apoptosis, metabolism, and 
differentiation to avoid clearance (27). Similar to Plasmodium, NFκB is one of the transcription factors 
manipulated to ensure successful infection (27). There are a few ways Toxoplasma affects NFκB and evades the 
immune defenses of the host. First, during infection, NFκB may lose subunits, overall increasing the 
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susceptibility during acute and chronic infections (27). By blocking the translocation of NFκB, the parasite can 
prevent the stimulation of pro-inflammatory genes like IL-12p40 and TNF-α (27). Lastly, NFκB can be 
manipulated to avoid apoptosis in cells infected with Toxoplasma by stimulating anti-apoptotic genes (24). 
2. Inhibiting Immune Signaling Pathways 
Toxoplasma suppresses critical signaling pathways like the JAK/STAT pathway, which is essential for 
activating vital cells responsible for fighting infections. The parasite does this by the delivery of proteins to the 
cell via specialized organelles called rhoptry and dense granule (16). During the invasion of the host cell, 
rhoptry proteins are deposited into the cell. These proteins will either localize in the cytoplasm or be trafficked 
into the nucleus. ROP16 is a Rhoptry protein that is translocated to the nucleus of the host cell and changes 
gene expression. Consequent to secretion, ROP16-I prevents activation of the JAK/STAT pathway by 
phosphorylating tyrosine residues on host STAT3 and STAT6 proteins (16). The phosphorylation causes a 
decrease in Th1 cytokine release due to the prolonged activation of the IL-4 signaling pathway. Th1 is 
necessary for activating immune cells like lymphocytes, neutrophils, and macrophages. Without these cells, the 
host is vulnerable to infection, promoting Toxoplasma survival (16). 
IFN-γ stimulation also initiates the JAK/STAT pathway, and Toxoplasma interferes with this process in two 
ways. First, Toxoplasma can indirectly affect the response of IFN-γ by upregulating suppressor of cytokine 
signaling proteins (SOCS) (27). These proteins can prevent IFN-γ action by inhibiting the catalytic activity of 
the JAKs or impeding the recruitment of STATs. Both of which benefit the parasite by inhibiting the action of 
STAT, allowing for widespread infection (27). Secondly, the parasite also inhibits the expression of IFN-γ 
responsive genes. Toxoplasma blocks the activation of these genes by hindering the dissociation of STAT1 from 
the DNA. Overall, impeding STAT1 recycling and further cycles of STAT1-mediated transcription (2).  
Toxoplasma inhibitor of STAT1-dependent transcription (TgIST) is a dense granule protein that is released into 
the host cell and trafficked into the nucleus. TgIST binds to phosphorylated STAT1 dimers, which bind to 
gamma-activated sequences in the promoters of IFN-stimulated genes (20). STAT1 is bound in the correct 
location to be activated; however, transcription is inhibited. This block caused by TgIST is due to the 
recruitment of nucleosome remodeling and repressive (NuRD) complex (20). TgIST also binds to the MI-
2/NuRD complex, which recruits it to activated STAT1 dimers (25). TgIST recruits the MI-2/NuRD to STAT1 
on gamma-activated factor (GAF) sites of its cognate-regulated genes in IFN-γ activated cells. TgIST remodels 
the local environment by creating a nonpermissive chromatin state that shuts down RNA polymerase II 
transcription. Preventing the transcription of IFN-stimulated genes promotes persistent Toxoplasma infection 
(25,13). Overall, inhibition of STAT1 aids parasite survival because it downregulates MHC, inducible NOS2, 





Figure 2: ROP16 phosphorylating STAT3 and STAT6 in host cell causing an upregulation of IL-4 thereby inhibiting the  
JAK/STAT pathway (28). 
 
 
3. Inhibiting Apoptosis 
Apoptosis is a useful protection mechanism performed by the host cell to prevent the spread of infection. 
Toxoplasma must, therefore, stop this process to persist. This parasite can arrest apoptosis via the extrinsic and 
intrinsic pathways (2). The intrinsic pathway of apoptosis is blocked due to the parasite causing a reduction in 
the secretion of cytochrome c from the mitochondria. Decreasing cytochrome c levels results in diminished 
cleavage of caspase 9 and caspase 3. Caspase 3 is the executioner caspase, meaning it is what initiates 
destruction of the cell. Toxoplasma affecting this protein is vital to the survival and spread of toxoplasmosis (2).  
The extrinsic pathway of apoptosis is blocked due to Toxoplasma interfering with caspase 8, which is a protein 
vital for starting apoptosis. Decreased levels of pro-caspase-8 lower its association with the death-inducing 





Figure 3: Toxoplasma inhibits the extrinsic apoptotic pathway by reducing levels of pro-caspase-8 overall, lowering its  
interaction with the death receptor (Left). Toxoplasma prevents the intrinsic apoptotic pathway by decreasing cytochrome  
c section affecting activation of caspase-3 (2). 
 
Conclusion: 
Apicomplexan Parasites evade their host's immune system in several ways, often controlling and inhibiting host 
function. Plasmodium and Toxoplasma both manipulate NFκB. Plasmodium releases CSP into the cytoplasm of 
hepatocytes to suppress NFκB and prevent the stimulation of inflammatory cytokines. Toxoplasma also can 
prevent activation of inflammation by causing NFκB to lose subunits, inhibit the transportation of the 
transcription factor, and govern it to release anti-apoptotic genes instead of pro-apoptotic genes. 
Evasion of the human immune system for a Plasmodium parasite involves inhibiting many processes that cause 
inflammation and apoptosis. This is a trait shared by Toxoplasma as well. A critical difference between the two 
parasites is that one area of focus to avoid immune defenses for malaria is the sequestration of infected RBCs 
and healthy RBCs as Toxoplasma does not do this.  
Another difference between these parasites is how they manipulate apoptotic pathways. Plasmodium, as it has 
two stages in the lifecycle, induces apoptosis at the end of their development in the liver in order to enter blood 
circulation to proceed to the blood stage. Toxoplasma, however, manipulates both the extrinsic and intrinsic 
pathway of apoptosis to avoid cell death and continue to spread.  
Understanding Toxoplasma infection is essential for two reasons. One, Toxoplasma can cause severe illness in 
growing fetuses, as well as immunocompromised individuals. The second reason is that Toxoplasma can be 
used as a model to study a more deadly relative, Plasmodium (27). More insight from research on malaria is 
vital for the development of successful treatment—awareness about how these parasites avoid clearance further 
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